ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

Trials Approved by NCI CTEP For the Month of April

April 27, 2012

Sledge Elected ASCO President

January 16, 2009

New Patterns Of Care Study Okayed By DCT Board

June 13, 1986

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

February 14, 2014